IL1B and Barrett esophagus: To study BE formation and progression to EAC in vivo, we established a mouse model expressing human IL-1beta cDNA downstream of an Epstein-Barr-Virus promoter (ED-L2), which targets the oral cavity, esophagus and squamous forestomach of the mouse2,3.